News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Top Concerns of Patients

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

A real-world study found Erleada reduced the risk of death compared with darolutamide in patients with metastatic castration-sensitive prostate cancer: © stock.adobe.com.

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

February 2nd 2026

breast cancer

CD47 Protein May Predict Evorpacept Success in Metastatic Breast Cancer

February 2nd 2026

FDA

FDA Grants Orphan Drug Status to IFx-2.0 for Advanced Melanoma Care

February 2nd 2026

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin Supplements May Complicate Cancer Care, Research Shows

February 2nd 2026

Dr. Pablo Prichard

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

ByDr. Pablo Prichard

February 1st 2026

Trending on CURE

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

Biotin Supplements May Complicate Cancer Care, Research Shows

Key GI Cancer Advances from the 2026 ASCO Symposium